|
NZ330216A
(en)
|
1996-01-16 |
2000-09-29 |
Bristol Myers Squibb Co |
Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and use in treatment of atherosclerosis
|
|
US20020168761A1
(en)
*
|
2000-01-24 |
2002-11-14 |
Gour Barbara J. |
Peptidomimetic modulators of cell adhesion
|
|
US20040006011A1
(en)
*
|
1996-07-12 |
2004-01-08 |
Gour Barbara J. |
Peptidomimetic modulators of cell adhesion
|
|
US6174905B1
(en)
|
1996-09-30 |
2001-01-16 |
Mitsui Chemicals, Inc. |
Cell differentiation inducer
|
|
US5760246A
(en)
*
|
1996-12-17 |
1998-06-02 |
Biller; Scott A. |
Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
|
|
US6307049B1
(en)
|
1998-09-30 |
2001-10-23 |
The Procter & Gamble Co. |
Heterocyclic 2-substituted ketoamides
|
|
GB9919778D0
(en)
|
1999-08-21 |
1999-10-27 |
Zeneca Ltd |
Chemical compounds
|
|
ES2316383T3
(es)
|
1999-09-17 |
2009-04-16 |
Millennium Pharmaceuticals, Inc. |
Benzamidas e inhibidores relacionados del factor xa.
|
|
WO2001056989A2
(en)
|
2000-02-01 |
2001-08-09 |
Cor Therapeutics, Inc. |
Inhibitors of factor xa
|
|
CN1173975C
(zh)
|
2000-04-27 |
2004-11-03 |
山之内制药株式会社 |
咪唑并吡啶衍生物
|
|
US6403588B1
(en)
*
|
2000-04-27 |
2002-06-11 |
Yamanouchi Pharmaceutical Co., Ltd. |
Imidazopyridine derivatives
|
|
AU2001273040A1
(en)
|
2000-06-27 |
2002-01-08 |
Du Pont Pharmaceuticals Company |
Factor xa inhibitors
|
|
US20040067938A1
(en)
|
2000-09-29 |
2004-04-08 |
Penglie Zhang |
Quaternary amines and related inhibitors of factor xa
|
|
AU2001295992A1
(en)
|
2000-10-24 |
2002-05-06 |
Sankyo Company Limited |
Imidazopyridine derivatives
|
|
US7429599B2
(en)
|
2000-12-06 |
2008-09-30 |
Signal Pharmaceuticals, Llc |
Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK
|
|
US7129242B2
(en)
|
2000-12-06 |
2006-10-31 |
Signal Pharmaceuticals, Llc |
Anilinopyrimidine derivatives as JNK pathway inhibitors and compositions and methods related thereto
|
|
GB0103926D0
(en)
|
2001-02-17 |
2001-04-04 |
Astrazeneca Ab |
Chemical compounds
|
|
SE0100569D0
(sv)
|
2001-02-20 |
2001-02-20 |
Astrazeneca Ab |
New compounds
|
|
ES2316546T3
(es)
|
2001-02-20 |
2009-04-16 |
Astrazeneca Ab |
2-arilamino-pirimidinas para el tratamiento de trastornos asociados a gsk3.
|
|
WO2003084997A1
(en)
|
2001-04-10 |
2003-10-16 |
Transtech Pharma, Inc. |
Probes, systems and methods for drug discovery
|
|
ATE337316T1
(de)
|
2001-06-21 |
2006-09-15 |
Smithkline Beecham Corp |
Imidazo 1,2-aöpyridin-derivate zur prophylaxe und behandlung von herpes-infektionen
|
|
WO2003000682A1
(en)
|
2001-06-25 |
2003-01-03 |
Merck & Co., Inc. |
(pyrimidyl)(phenyl)substituted fused heteroaryl p38 inhibiting and pkg kinase inhibiting compounds
|
|
EP1270551A1
(en)
|
2001-06-26 |
2003-01-02 |
Aventis Pharma Deutschland GmbH |
Urea derivatives with antiproteolytic activity
|
|
US7868204B2
(en)
*
|
2001-09-14 |
2011-01-11 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
|
EP1432712B1
(en)
|
2001-10-05 |
2006-05-17 |
SmithKline Beecham Corporation |
Imidazo-pyridine derivatives for use in the treatment of herpes viral infection
|
|
WO2003041649A2
(en)
|
2001-11-13 |
2003-05-22 |
Merck Frosst Canada & Co. |
Cyanoalkylamino derivatives as protease inhibitors
|
|
US6995144B2
(en)
|
2002-03-14 |
2006-02-07 |
Eisai Co., Ltd. |
Nitrogen containing heterocyclic compounds and medicines containing the same
|
|
JP2003313126A
(ja)
|
2002-04-23 |
2003-11-06 |
Sankyo Co Ltd |
イミダゾピリジン誘導体を有効成分とする医薬
|
|
JP2004002826A
(ja)
|
2002-04-24 |
2004-01-08 |
Sankyo Co Ltd |
高分子イミダゾピリジン誘導体
|
|
GB0212049D0
(en)
|
2002-05-24 |
2002-07-03 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
US20040034084A1
(en)
|
2002-05-24 |
2004-02-19 |
Celgene Corporation |
Methods for using JNK inhibitors for treating or preventing disease-related wasting
|
|
CA2388358A1
(en)
|
2002-05-31 |
2003-11-30 |
Voiceage Corporation |
A method and device for multi-rate lattice vector quantization
|
|
JP3725105B2
(ja)
*
|
2002-08-30 |
2005-12-07 |
株式会社東芝 |
二次電池の過放電防止回路及び二次電池の過放電防止法
|
|
UA80296C2
(en)
|
2002-09-06 |
2007-09-10 |
Biogen Inc |
Imidazolopyridines and methods of making and using the same
|
|
AU2003273701A1
(en)
|
2002-10-17 |
2004-05-04 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
|
US20040087642A1
(en)
|
2002-10-24 |
2004-05-06 |
Zeldis Jerome B. |
Methods of using and compositions comprising a JNK inhibitor for the treatment, prevention, management and/or modification of pain
|
|
US20040092568A1
(en)
|
2002-10-31 |
2004-05-13 |
Zeldis Jerome B. |
Methods for the treatment, prevention and management of macular degeneration
|
|
JP2006508997A
(ja)
|
2002-11-28 |
2006-03-16 |
シエーリング アクチエンゲゼルシャフト |
Ｃｈｋ−、Ｐｄｋ−およびＡｋｔ−阻害性ピリミジン、それらの製造および薬剤としての使用
|
|
US20050019366A1
(en)
|
2002-12-31 |
2005-01-27 |
Zeldis Jerome B. |
Drug-coated stents and methods of use therefor
|
|
US7135493B2
(en)
*
|
2003-01-13 |
2006-11-14 |
Astellas Pharma Inc. |
HDAC inhibitor
|
|
TW200424174A
(en)
|
2003-02-06 |
2004-11-16 |
Hoffmann La Roche |
New TP diamide
|
|
US7208491B2
(en)
|
2003-02-07 |
2007-04-24 |
Hoffmann-La Roche Inc. |
N-monoacylated o-phenylenediamines
|
|
WO2004076452A1
(en)
|
2003-02-26 |
2004-09-10 |
Merck Sharp & Dohme Limited |
5,8-DIFLUOROIMIDAZO[1,2-a]PYRIDINES AS GABA-A α2/α3 LIGANDS FOR TREATING ANXIETY AND/OR DEPRESSION
|
|
US7320989B2
(en)
*
|
2003-02-28 |
2008-01-22 |
Encysive Pharmaceuticals, Inc. |
Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists
|
|
JP2006520819A
(ja)
|
2003-03-06 |
2006-09-14 |
メルク エンド カムパニー インコーポレーテッド |
抗原虫薬イミダゾピリジン化合物
|
|
BRPI0409227C1
(pt)
|
2003-04-07 |
2021-05-25 |
Axys Pharm Inc |
composto, composição farmacêutica, uso de um composto e processo para a preparação de um composto de fórmula (i)
|
|
US20050234066A1
(en)
*
|
2004-04-15 |
2005-10-20 |
Agouron Pharmaceuticals, Inc. |
Alpha substituted carboxylic acids
|
|
AP2005003418A0
(en)
|
2003-04-15 |
2005-12-31 |
Pfizer |
Alpha substituted carboxylic acids as ppar modulators.
|
|
US20050187266A1
(en)
|
2003-04-15 |
2005-08-25 |
Pfizer Inc |
Alpha substituted carboxylic acids
|
|
WO2004110350A2
(en)
|
2003-05-14 |
2004-12-23 |
Torreypines Therapeutics, Inc. |
Compouds and uses thereof in modulating amyloid beta
|
|
WO2005006945A2
(en)
|
2003-07-03 |
2005-01-27 |
The Salk Institute For Biological Studies |
Methods for treating neural disorders and compounds useful therefor
|
|
WO2005030705A1
(en)
|
2003-09-24 |
2005-04-07 |
Methylgene, Inc. |
Inhibitors of histone deacetylase
|
|
EP2210607B1
(en)
|
2003-09-26 |
2011-08-17 |
Exelixis Inc. |
N-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]quinolin-4-yl}oxy)phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide for the treatment of cancer
|
|
KR20060124610A
(ko)
|
2003-11-06 |
2006-12-05 |
셀진 코포레이션 |
석면-관련된 질환 또는 장애를 치료 및 관리하기 위하여ｊｎｋ 억제제를 사용하는 방법 및 이 물질을 포함하는조성물
|
|
US7524851B2
(en)
|
2003-12-05 |
2009-04-28 |
Robert Bosch Gesellschaft Fur Medizinische Forschung (Rbmf) |
Diagnostic methods for therapeutic compounds and methods for monitoring azathioprine therapy
|
|
WO2005060571A2
(en)
|
2003-12-10 |
2005-07-07 |
Merck & Co., Inc. |
Antiprotozoal imidazopyridine compounds
|
|
US7671181B2
(en)
|
2004-01-16 |
2010-03-02 |
Merck Sharp & Dohme Corp. |
Polynucleotides encoding coccidian parasite casein kinase I, a chemotherapeutic target for antiprotozoal agents
|
|
WO2005077368A2
(en)
|
2004-02-03 |
2005-08-25 |
Astrazeneca Ab |
Treatment of gastro-esophageal reflux disease (gerd)
|
|
WO2005077373A2
(en)
|
2004-02-03 |
2005-08-25 |
Astrazeneca Ab |
Treatment of gastro-esophageal reflux disease (gerd)
|
|
DE102004008141A1
(de)
|
2004-02-19 |
2005-09-01 |
Abbott Gmbh & Co. Kg |
Guanidinverbindungen und ihre Verwendung als Bindungspartner für 5-HT5-Rezeptoren
|
|
US20070093492A1
(en)
*
|
2004-03-09 |
2007-04-26 |
Weir-Torn Jiaang |
Pyrrolidine derivatives
|
|
MXPA06010900A
(es)
*
|
2004-03-26 |
2007-02-21 |
Methylgene Inc |
Inhibidores de histona desacetilasa.
|
|
US7253204B2
(en)
*
|
2004-03-26 |
2007-08-07 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
|
WO2005102318A1
(en)
|
2004-04-20 |
2005-11-03 |
Ab Science |
Use of c-kit inhibitors for treating hiv related diseases
|
|
US20080146585A1
(en)
|
2004-04-20 |
2008-06-19 |
Ab Science |
Use Of C-Kit Inhibitors For Treating Inflammatory Muscle Disorders Including Myositis And Muscular Dystrophy
|
|
AU2005236055B2
(en)
|
2004-04-20 |
2011-10-06 |
Transtech Pharma, Llc |
Substituted thiazole and pyrimidine derivatives as melanocortin receptor modulators
|
|
JP2007533731A
(ja)
|
2004-04-23 |
2007-11-22 |
アブ サイエンス |
マラリア原虫関連の疾病を処置するためのｃ−ｋｉｔ阻害剤の使用法
|
|
WO2005102326A2
(en)
|
2004-04-23 |
2005-11-03 |
Ab Science |
Use of c-kit inhibitors for treating renal diseases
|
|
WO2005102346A2
(en)
|
2004-04-23 |
2005-11-03 |
Ab Science |
Use of c-kit inhibitors for treating fibrosis
|
|
WO2005111044A1
(en)
*
|
2004-05-17 |
2005-11-24 |
Tibotec Pharmaceuticals Ltd. |
4-substituted-1,5-dihydro-pyrido[3,2-b]indol-2-ones
|
|
JP2007538064A
(ja)
|
2004-05-18 |
2007-12-27 |
アブ サイエンス |
化学または生物兵器に曝露された患者を処置するための肥満細胞阻害剤の使用法
|
|
WO2005115385A1
(en)
|
2004-05-24 |
2005-12-08 |
Ab Science |
Use of c-kit inhibitors for treating acne
|
|
WO2005115304A2
(en)
|
2004-05-24 |
2005-12-08 |
Ab Science |
Use of c-kit inhibitors for treating fibrodysplasia
|
|
KR101261305B1
(ko)
|
2004-07-28 |
2013-05-08 |
얀센 파마슈티카 엔.브이. |
히스톤 디아세틸라제의 신규한 저해제로의 치환된 인돌릴알킬 아미노 유도체
|
|
WO2006038001A1
(en)
|
2004-10-06 |
2006-04-13 |
Celltech R & D Limited |
Aminopyrimidine derivatives as jnk inhibitors
|
|
AU2005295734A1
(en)
|
2004-10-15 |
2006-04-27 |
Biogen Idec Ma Inc. |
Methods of treating vascular injuries
|
|
ZA200704889B
(en)
|
2004-11-23 |
2008-09-25 |
Celgene Corp |
JNK inhibitors for treatment of CNS injury
|
|
KR20070094754A
(ko)
|
2004-12-01 |
2007-09-21 |
데브젠 엔브이 |
이온 채널, 특히 Ｋｖ 패밀리로부터의 이온 채널과상호작용하는 5-카복사미도 치환된 티아졸 유도체
|
|
MX2007007272A
(es)
|
2004-12-17 |
2007-07-11 |
Astrazeneca Ab |
4-(4-imidazol-4-il)pirimidin-2-ilamino)benzamidas como inhibidores de cdk.
|
|
WO2006070943A1
(ja)
|
2004-12-28 |
2006-07-06 |
Takeda Pharmaceutical Company Limited |
縮合イミダゾール化合物およびその用途
|
|
EP1841766A1
(en)
|
2005-01-19 |
2007-10-10 |
Biolipox AB |
Pyrrolopyridines useful in the treatment of inflammation
|
|
EP1858513A4
(en)
*
|
2005-03-09 |
2009-06-03 |
Merck & Co Inc |
DIPHENYL-SUBSTITUTED CYCLOALCANES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHOD FOR THEIR USE
|
|
US20060223807A1
(en)
|
2005-03-29 |
2006-10-05 |
University Of Massachusetts Medical School, A Massachusetts Corporation |
Therapeutic methods for type I diabetes
|
|
EP1874759A4
(en)
|
2005-04-06 |
2009-07-15 |
Exelixis Inc |
C-MET MODULATORS MODULATORS AND METHODS OF USE
|
|
UA92746C2
(en)
|
2005-05-09 |
2010-12-10 |
Акилайон Фармасьютикалз, Инк. |
Thiazole compounds and methods of use
|
|
JP4528918B2
(ja)
|
2005-06-21 |
2010-08-25 |
学校法人 関西大学 |
カルボキサミド誘導体
|
|
CN101223161A
(zh)
*
|
2005-06-24 |
2008-07-16 |
健亚生物科技公司 |
治疗病毒感染的杂芳基衍生物
|
|
US7309787B2
(en)
|
2005-07-13 |
2007-12-18 |
Allergan, Inc. |
Kinase inhibitors
|
|
US20080207572A1
(en)
|
2005-07-14 |
2008-08-28 |
Ab Science |
Use of Dual C-Kit/Fgfr3 Inhibitors for Treating Multiple Myeloma
|
|
AU2006287767B2
(en)
|
2005-09-07 |
2010-05-13 |
Merck Serono Sa |
IKK inhibitors for the treatment of endometriosis
|
|
EP2407459A1
(en)
|
2005-09-27 |
2012-01-18 |
Shionogi & Co., Ltd. |
Synthetic intermediate in the production of a sulfonamide derivative having PGD2 receptor antagonistic activity
|
|
AR056556A1
(es)
|
2005-09-30 |
2007-10-10 |
Astrazeneca Ab |
Imidazo(1,2-a)piridina con actividad antiproliferacion celular
|
|
UY29827A1
(es)
|
2005-10-03 |
2007-05-31 |
Astrazeneca Ab |
2-amina-pirimidina-4-(2-metil-1-(tetrahidro-2h-piran-4-il)-1-imidazol-5-y1) sustituidas y sus derivados, composiciones farmacéuticas que las contienen, procesos para su preparación y aplicaciones
|
|
ITMI20060296A1
(it)
|
2006-02-17 |
2007-08-18 |
Alberto Lodolo |
Dispositivo di intercettazione multifunzionale
|
|
WO2007100795A2
(en)
*
|
2006-02-27 |
2007-09-07 |
Gilead Colorado, Inc. |
Combinations comprising a histone deacetylase inhibiting agent and a nuclear hormone receptor ligand for treating cardiovascular conditions
|
|
CA2649861A1
(en)
|
2006-04-26 |
2007-11-08 |
Merck & Co., Inc. |
Disubstituted aniline compounds
|
|
CA2690192A1
(en)
*
|
2007-06-26 |
2008-12-31 |
Gilead Colorado, Inc. |
Imidazopyridinyl thiazolyl histone deacetylase inhibitors
|
|
CA2729909A1
(en)
*
|
2008-07-14 |
2010-01-21 |
Gilead Sciences, Inc. |
Imidazolyl pyrimidine inhibitor compounds
|
|
US8124764B2
(en)
*
|
2008-07-14 |
2012-02-28 |
Gilead Sciences, Inc. |
Fused heterocyclyc inhibitor compounds
|
|
CN102123987A
(zh)
|
2008-07-28 |
2011-07-13 |
吉里德科学公司 |
亚环烷基和亚杂环烷基组蛋白脱乙酰酶抑制剂化合物
|
|
US8283357B2
(en)
*
|
2009-06-08 |
2012-10-09 |
Gilead Sciences, Inc. |
Cycloalkylcarbamate benzamide aniline HDAC inhibitor compounds
|
|
KR20120031170A
(ko)
*
|
2009-06-08 |
2012-03-30 |
길리애드 사이언시즈, 인코포레이티드 |
알카노일아미노 벤즈아미드 아닐린 ｈｄａｃ 저해제 화합물
|